Serono Serostim recombinant hGH for AIDS wasting approved Aug. 23.
Executive Summary
SERONO SEROSTIM hGH APPROVED AUG. 23 FOR AIDS WASTING and cachexia based on clinicals conducted for up to 12 weeks' duration. Results from one clinical trial show that Serostim increased lean body mass (weight and muscle) increased by an average of 1.6 kg (3.5 lbs.) compared to placebo. The most common adverse events were tissue swelling and joint and muscle pain.